Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis

Background: Methamphetamine (METH) is considered the second most commonly abused drug in the world. There is limited or no evidence concerning the effective treatment of METH withdrawal symptoms, such as depression and anxiety. Mode of action of selegiline (increase of the brain neurotransmitter act...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mir-Jamal Hosseini, Sima Askari Sadat-Mahaleh, Hamed Ghavimi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Tabriz University of Medical Sciences 2022-04-01
Serie:	Pharmaceutical Sciences
Soggetti:	selegiline methamphetamine depression mitochondrion oxidative stress fluoxetine
Accesso online:	https://ps.tbzmed.ac.ir/PDF/ps-28-251.pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!